Quick Answer
Jazz Pharmaceuticals plc reported Long Term Debt of $4.33 billion for the year ending 2025.
- Jazz Pharmaceuticals plc showed a decrease of -28.8% in Long Term Debt from 2024 to 2025.
- This data is from Jazz Pharmaceuticals plc's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: $444.19 million | Q3 2012: $435.63 million | Q1 2013: $418.51 million | Q2 2013: $546.72 million | Q3 2013: $545.56 million | Q1 2014: $1.19 billion | Q2 2014: $1.19 billion | Q3 2014: $1.33 billion | Q1 2015: $1.33 billion | Q2 2015: $1.34 billion | Q3 2015: $1.17 billion | Q1 2016: $1.15 billion | Q2 2016: $1.14 billion | Q3 2016: $2.15 billion | Q1 2017: $1.74 billion | Q2 2017: $1.64 billion | Q3 2017: $1.54 billion | Q1 2018: $1.54 billion | Q2 2018: $1.56 billion | Q3 2018: $1.56 billion | Q1 2019: $1.57 billion | Q2 2019: $1.57 billion | Q3 2019: $1.57 billion | Q1 2020: $1.58 billion | Q2 2020: $2.07 billion | Q3 2020: $1.84 billion | Q1 2021: $1.85 billion | Q2 2021: $6.49 billion | Q3 2021: $6.25 billion | Q1 2022: $5.99 billion | Q2 2022: $5.99 billion | Q3 2022: $5.70 billion | Q1 2023: $5.69 billion | Q2 2023: $5.69 billion | Q3 2023: $5.11 billion | Q1 2024: $5.11 billion | Q2 2024: $5.10 billion | Q3 2024: $6.08 billion | Q1 2025: $5.34 billion | Q2 2025: $4.34 billion | Q3 2025: $4.33 billion.
- Historical annual values: Fiscal year 2025: $4.33 billion | Fiscal year 2024: $6.08 billion | Fiscal year 2023: $5.11 billion | Fiscal year 2022: $5.69 billion | Fiscal year 2021: $6.02 billion | Fiscal year 2020: $1.85 billion | Fiscal year 2019: $1.57 billion | Fiscal year 2018: $1.56 billion | Fiscal year 2017: $1.54 billion | Fiscal year 2016: $1.99 billion | Fiscal year 2015: $1.15 billion | Fiscal year 2014: $1.33 billion | Fiscal year 2013: $544.40 million | Fiscal year 2012: $427.07 million | Fiscal year 2011: $0.00.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: